Binary Genomics, Inc.

Madison, CT

UEI
FVZKKWHC58Q6
CAGE
8PWU8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
27 Allison Dr, Madison, CT 06443, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Binary Genomics, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Monitoring immunotherapy response via gene silencing landscapes in cell-free DNA - abstract: immunotherapies produce… Grant · R44CA285041 National Cancer Institute $1,999,999
Monitoring immunotherapy response via gene silencing landscapes in cell-free DNA - abstract: immunotherapies produce… Grant · R43CA285041 National Cancer Institute $398,040

SBA capabilities narrative

From the vendor's SBA profile

Binary Genomics develops blood tests for cancer diagnostics

Quick answers

What is Binary Genomics, Inc.'s UEI?

Binary Genomics, Inc.'s Unique Entity ID (UEI) in SAM.gov is FVZKKWHC58Q6.

What is Binary Genomics, Inc.'s CAGE code?

Binary Genomics, Inc.'s CAGE code is 8PWU8.

What is Binary Genomics, Inc.'s primary NAICS code?

Binary Genomics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Binary Genomics, Inc. located?

Binary Genomics, Inc.'s physical address in SAM.gov is 27 Allison Dr, Madison, CT 06443, USA.

Is Binary Genomics, Inc. registered in SAM.gov?

Yes. Binary Genomics, Inc.'s SAM.gov registration is active through March 21, 2027.

What is Binary Genomics, Inc.'s most recent federal award?

Binary Genomics, Inc.'s most recent federal grant award is Monitoring immunotherapy response via gene silencing landscapes in cell-free DNA - abstract: immunotherapies produce… (R44CA285041), from National Cancer Institute, on September 17, 2024.

On GovTribe

See Binary Genomics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login